Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. The audited financial ....
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has informed stock exchanges that its Board of Directors will meet on Friday, May 30, 2025. The key agenda items are to consider and approve the audited financial results for the quarter and full year ended March 31, 2025, and to recommend a dividend, if any, on equity shares for FY 2024-25. The trading window for designated persons remains closed from March 16, 2025 to June 1, 2025, in line with insider trading regulations. This is a routine pre-results announcement and does not contain any actual financial figures at this stage.
No immediate impact on shareholders — this is a standard advance notice. Investors should watch the May 30 results for actual revenue, profit, and dividend numbers, which could move the stock once announced.